1. Schedule II consists of the drugs listed
in this section, by whatever official, common, usual, chemical or trade name
designated.
2. Unless specifically
excepted or unless listed in another schedule, any of the following substances,
whether produced directly or indirectly by extraction from substances of
vegetable origin, or independently by means of chemical synthesis, or by
combination of extraction and chemical synthesis, is hereby enumerated in
schedule II:
(a) Opium and opiate, and any
salt, compound, derivative or preparation of opium or opiate, excluding
apomorphine, thebaine-derived butorphanol, dextrorphan, nalbuphine, nalmefene,
naloxone and naltrexone, and their respective salts, but including:
Codeine;
Diprenorphine;
Ethylmorphine;
Etorphine hydrochloride;
Granulated opium;
Hydrocodone;
Hydrocodone combination product (meaning any product that
contains hydrocodone in combination with any other active ingredient);
Hydromorphone;
Metopon;
Morphine;
Opium extracts;
Opium fluid;
Powdered opium;
Raw opium;
Oxycodone;
Oxymorphone;
Thebaine; and
Tincture of opium.
(b) Any salt, compound, isomer, derivative or
preparation thereof which is chemically equivalent or identical with any of the
substances referred to in paragraph (a) if they do not include the isoquinoline
alkaloids of opium.
(c) Opium poppy
and poppy straw.
(d) Cocaine
hydrochloride salt prepared by a registered chemical or pharmaceutical
manufacturer of the Drug Enforcement Administration of the Department of
Justice which is properly labeled, including lot numbers, and is available for
medicinal purposes through a distribution system approved by the Drug
Enforcement Administration.
(e)
Benzolyecgonine or ecgonine.
(f)
Concentrate of poppy straw (meaning the crude extract of poppy straw in either
liquid, solid or powder form and containing the phenanthrene alkaloids of the
opium poppy).
3. Unless
specifically excepted or unless listed in another schedule, any of the
following opiates, including their isomers, esters, ethers, salts and salts of
isomers, esters and ethers, whenever the existence of such isomers, esters,
ethers and salts is possible within the specific chemical designation
(dextrorphan and levopropoxyphene excepted), are hereby enumerated on schedule
II:
Alfentanil;
Alphaprodine;
Anileridine;
Bezitramide;
Bulk dextropropoxyphene (in nondosage forms);
Carfentanil;
Dihydrocodeine;
Diphenoxylate;
Fentanyl;
Isomethadone;
Levo-alphacetylmethadol (some trade or other names:
levo-alpha-acetylmethadol; levomethadyl acetate; LAAM);
Levomethorphan;
Levorphanol;
Metazocine;
Methadone;
Methadone-Intermediate, 4-cyano-2-dimethylamino-4,
4-diphenylbutane;
Moramide-Intermediate, 2-methyl-3-morpholino-1,
1-diphenylpropane-carboxylic acid;
Pethidine (meperidine);
Pethidine-Intermediate-A,
4-cyano-1-methyl-4-phenylpiperidine;
Pethidine-Intermediate-B,
ethyl-4-phenylpiperdine-4-carboxylate;
Pethidine-Intermediate-C,
1-methyl-4-phenylpiperidine-4-carboxylic acid;
Phenazocine;
Piminodine;
Racemethorphan;
Racemorphan;
Ramifentanil;
Sufentanil; or
Tapentadol.
4. Unless specifically excepted or unless
listed in another schedule, any material, compound, mixture or preparation
which contains any quantity of the following substances having a stimulant
effect on the central nervous system is hereby enumerated on schedule II:
(a) Amphetamine, its salts, optical isomers
and salts of optical isomers;
(b)
Phenmetrazine and its salts;
(c)
Unless specifically excepted, any preparation which contains any quantity of
methamphetamine, including its salts, isomers and salts of isomers, prepared by
a registered chemical or pharmaceutical manufacturer of the Drug Enforcement
Administration of the Department of Justice, which is properly labeled,
including lot numbers, and is available for medicinal purposes through a
distribution system approved by the Drug Enforcement Administration;
(d) Methylphenidate; or
(e) Lisdexamfetamine.
5. Unless specifically excepted or unless
listed in another schedule, any material, compound, mixture or preparation
which contains any quantity of the following substances having a depressant
effect on the central nervous system, including their salts, isomers and salts
of isomers, whenever the existence of such salts, isomers and salts of isomers
is possible within the specific chemical designation, is hereby enumerated on
schedule II:
Amobarbital;
Glutethimide;
Pentobarbital; or
Secobarbital.
6. Unless specifically excepted or unless
listed in another schedule, any material, compound, mixture or preparation
which contains any quantity of the following substances is hereby enumerated on
schedule II:
(a) Immediate precursors to
phencyclidine (PCP):
1-Phenylcyclohexylamine; or
1-piperidinocyclohexanecarbonitrile (PCC).
(b) Immediate precursors to amphetamine and
methamphetamine:
Phenylacetone (some trade or other names: phenyl-2-propanone;
P2P; benzyl methyl ketone; methyl benzyl ketone).
(c) Immediate precursors to fentanyl:
4-anilino-N-phenethylpiperidine (some trade or other names:
4-ANPP; ANPP; 4-anilino-N-phenethyl-4-piperidine; despropionyl fentanyl;
4-Aminophenyl-1-phenethylpiperidine;
N-phenyl-1-(2-phenylethyl)-4-piperidinamine)
7. Any material, compound, mixture or
preparation which contains any quantity of Nabilone (commonly referred to as:
(+)-trans-3-(1,1-dimethylheptyl)-6, 6a,
7,8,10,10a-hexahydro-1-hydroxy-6,6-dimethyl-9H- dibenzol[b,d]pyran-9-one) is
hereby enumerated on schedule II.
8. Dronabinol oral solution in a drug product
approved by the United States Food and Drug Administration (some trade or other
names:
(6aR,10aR)-6a,7,8,10a-Tetrahydro-6,6,9-trimethyl-3-penthyl-6H-dibenzo[b,d]-pyran-1-ol;
(-)-delta-9-trans-tetrahydrocannabinol; Syndros) is hereby enumerated on
schedule II.
